Welcoming Olive to the Oak HC/FT Family!

Welcoming Olive to the Oak HC/FT Family!

Originally published on Oak HC/FT

Today, we led the Series D financing in Olive (formerly known as CrossChx), the leading healthcare provider of robotic process automation (“RPA”) tools. Through its eponymous platform, the company streamlines repetitive, high-volume tasks by leveraging the systems and tools that its customers already have in place without complex integrations. Leveraging AI, Olive helps hospitals and health systems reduce costs, eliminate clerical error, boost efficiency, and improve satisfaction.

Our investment in Olive is the result of our thematic pursuit for solutions that help drive efficiency and lower costs using automation technology. While Olive is not unique in providing RPA solutions, we have yet to come across another company with as much proven expertise in solving challenges unique to healthcare. Sean Lane, the CEO and founder of Olive, and his team have developed a platform that delivers an immense amount of value without needing to fundamentally change the way its customers do business.

We spoke with many of Olive’s customers all of whom confirmed how integral the technology has become to their day-to-day operations. Many users referred to Olive as another member of their team, describing the work “she” did, stating they couldn’t imagine their workflow without “her.” This is the sort of thing that really underscores how Olive goes far beyond a typical software solution.

The use cases for Olive within the healthcare ecosystem are seemingly endless and we see them as only continuing to grow as the company expands with next-generation technology like Pupil, the company’s process mining solution. We look forward to partnering with the company to support growth strategies and scale the business. Alongside Ascension Ventures, Drive Capital, SVB Capital, and the other existing investors participating in this round, we at Oak HC/FT could not be more excited to partner with Sean and his team on their journey.

NCI Forms Innovative AI Partnership with CrossChx

NCI Forms Innovative AI Partnership with CrossChx


NCI, Inc. (“NCI”), a leading provider of advanced information technology (IT) solutions and professional services to U.S. Federal Government agencies, announced today that it has entered into an exclusive partnership with Columbus, Ohio-based CrossChx, Inc. Under the partnership, CrossChx will work with NCI to bring its artificial intelligence (AI) commercial capabilities to government customers, enhancing NCI’s quality of premier solutions while simultaneously creating new opportunities for NCI employees.

“We look forward to partnering with CrossChx to bring our customers an innovative new solution to increase efficiencies while delivering greater mission success,” said Paul A. Dillahay, president and CEO of NCI. “Our solutions will address human capital needs, especially for functions that allow people more opportunity to manage rather than manually operate those processes. This helps to remove elements of human error, boost workforce focus on solutions and innovation, and ultimately result in better outcomes for both our customers and employees.”

NCI’s AI capabilities will be unique in the market through a focus on scaling humans, an AI approach that uses continual machine learning and automated processes to build greater workforce and organizational results. Through this partnership, NCI intends to explore opportunities to improve the efficiency of its current operations, providing true interoperability and collaboration between customers, employees and AI systems.

NCI launched seven pilots in August 2017, utilizing the CrossChx AI platform to provide proof of concepts across areas such as fraud, waste and abuse, cybersecurity, machine-to-machine communication (M2M) and patient care coordination. NCI plans to deploy these capabilities in several customer environments beginning in 2018 and will have a patient care demonstration available at the HIMSS18 Conference and Exhibition in Las Vegas from March 5-9, 2018.

“CrossChx is excited for the opportunity to help NCI build out their AI capabilities,” said Sean Lane, co-founder and CEO of CrossChx. “We anticipate implementing AI solutions across all of NCI’s operations in order to help them increase speed and productivity for their clients. After finding immense success in helping healthcare facilities adopt operational AI with our solution Olive, we are eager to bring this technology to the federal government where we think it will make a significant impact.”

About NCI, Inc.:
NCI is a leading provider of enterprise solutions and services to U.S. defense, intelligence, health and civilian government agencies. The company has the expertise and proven track record to solve its customers’ most important and complex mission challenges through technology and innovation. With core competencies in delivering cost-effective solutions and services in areas such as agile digital transformation; advanced analytics; hyperconverged infrastructure solutions; fraud, waste and abuse; and engineering and logistics; NCI’s team of highly skilled professionals are expanding their portfolio to include game-changing technology offerings such as artificial intelligence for their government customers. Coupled with a refined focus on strategic partnerships, NCI is successfully bridging the gap between commercial best practices and mission-critical government processes. Headquartered in Reston, Virginia, NCI has approximately 2,000 employees operating at more than 100 locations worldwide. For more information, visit www.nciinc.com.

About CrossChx:
Founded in 2012, CrossChx is building operational artificial intelligence, which empowers humans to achieve more than ever before. Olive, the company’s AI solution, acts as the intelligent router between systems and data by automating repetitive, high volume tasks and workflows providing true interoperability for organizations. Headquartered in Columbus, Ohio, CrossChx has a mission to scale humans by allowing AI to operate existing systems and letting it do what machines do best. For more information, visit www.hireolive.com or email olive@crosschx.com.

NCI, Inc.
Amanda Hall, 703-707-6677
Director, Corporate Communications
Joel Chakra, 301-792-1720
Head of Product Marketing

CrossChx Partners with RightPatient to Offer Cloud-Based Biometric Patient Identification Service

July 14, 2017 – CrossChx and RightPatient announced today a partnership enabling CrossChx customers to leverage RightPatient’s unique biometric patient identification service and photo biometrics capabilities. Under the partnership, CrossChx customers can easily transition their existing SafeChx biometrics solution to RightPatient, while continuing to utilize other CrossChx products such as Olive artificial intelligence.

The healthcare industry is plagued by patient identification challenges that cost hospitals over $17 million per year on average and jeopardize patient safety, data integrity, security, and quality of care. Organizations such as CHIME, AHIMA, HIMSS, HFMA, and the ECRI Institute have continued to highlight the danger that inaccurate patient identification can pose, while advocating for the use of patient photos and biometrics.

RightPatient is a scalable, cloud-based biometric patient identification service that instantly and accurately identifies patients by simply capturing their photo. The service also publishes the patient photos throughout provider ecosystems and is utilized by dozens of health systems such as Novant Health and Community Medical Centers to improve revenue cycle, patient safety, and more by preventing patient misidentifications.

CrossChx provides artificial intelligence using global identity resolution and machine learning to automate tasks and operational workflows in an enterprise.

“With our deep experience in biometric technology, versatile cloud-based patient identification service, and simple deployment model, this partnership is a perfect fit for CrossChx and their customers,” commented Michael Trader, Co-Founder of RightPatient. “CrossChx customers can now easily migrate to a biometric solution that multiplies their return, while continuing to leverage complementary CrossChx solutions for patient check-in and artificial intelligence.”

“We are very pleased to form a strategic partnership with RightPatient. By combining CrossChx’s expertise in artificial intelligence and identity resolution with Right Patient’s impressive biometric capabilities, we can define exciting new opportunities for transformation across healthcare.” said Sean Lane, Co-Founder and CEO of CrossChx.”

About RightPatient®

RightPatient® is the industry’s most versatile and scalable biometric patient identification service. The cloud-based solution is utilized by hospitals and health systems that collectively see over 45 million patients annually and represent nearly 1,000 healthcare locations. These forward-thinking providers process tens of thousands of daily transactions through RightPatient® to prevent duplicate medical records, eliminate medical identity theft, and increase patient safety. Interfaces already exist for various EHR systems, including Epic, Cerner, McKesson, Siemens, Meditech, CPSI and more. Backed by 15 years of experience in biometrics, cloud-computing, integration, and large-scale projects, we are dedicated to innovation and helping to achieve the “Triple Aim” by accurately recognizing patients from every encounter end point.


John Trader
VP of Communications

About CrossChx

CrossChx is building the Internet of Healthcare, which will give people a better way to connect and share their health information. Olive, the company’s artificial intelligence solution, acts as a 24/7 Virtual Care Assistant by automating repetitive, high volume tasks and workflows, including eligibility, prior authorizations, appointment reminders, and more. Headquartered in Columbus, Ohio, CrossChx has partnered with hundreds of health systems nationwide and created more than 70 million unique patient IDs for healthcare.


CrossChx, Inc.
Joel Chakra
Head of Marketing


World-Renowned Physician Dr. David Agus Joins CrossChx Board of Directors

COLUMBUS, Ohio October 12, 2016

CrossChx, the company giving people a better way to connect and share information about their health, announced today the addition of accomplished biomedical researcher, world renowned oncologist and entrepreneur, Dr. David Agus, to its board of directors. Effective immediately, Dr. Agus, also a New York Times bestselling author, will serve as a key adviser to the company’s executive team and contribute to the long-term goal of using technology to extend life expectancy.

“Dr. Agus is well regarded for his ability to take conventional wisdom and turn it on its head, so naturally we felt he would fit in well at CrossChx,” said Sean Lane, CEO and Co-Founder of CrossChx. “His experience and knowledge will help us continue to build better ways for people to connect and share their health information. We share a supercharged focus on making people healthier by strengthening and enriching the relationships between patients, payers, and providers.”

Dr. Agus is a professor of medicine and engineering at the University of Southern California (USC) Keck School of Medicine and Viterbi School of Engineering and the CEO and founding director of USC’s Lawrence J. Ellison Institute for Transformative Medicine. He is one of the world’s leading physicians specializing in treating patients with advanced forms of cancer, is the co-founder of several personalized medicine companies and has served in leadership roles at the World Economic Forum.

“This company’s hard work and determination to completely rethink and retool the way patients connect to their health immediately caught my attention and their growth is remarkable,” said Dr. Agus. “The work CrossChx is doing will forever change the way we experience healthcare and interact with our health information. I’m excited to be part of the team.”

Well regarded for his innovations in medicine, Dr. Agus has built a reputation for taking a unique approach to looking at the relationship of the human body to health and disease. Over the years he has treated a number of high-profile patients, including Apple Co-Founder Steve Jobs, musician Neil Young and former U.S. Senator Ted Kennedy among many others. He appears on television regularly as a medical contributor for CBS News.

“The End of Illness,” Dr. Agus’ first book published in 2012, is a New York Times #1 and international bestseller and was the subject of a television series on PBS. His most recent books “A Short Guide to a Long Life” and The Lucky Years: How to Thrive in the Brave New World of Health are also New York Times and international bestsellers.

Dr. Agus holds degrees from Princeton University and the University of Pennsylvania School of Medicine, and currently lives in California with his wife and two children.

Healthcare Startup CrossChx Raises $15 Million to Expand Unique Patient Identifier Across the United States

COLUMBUS, Ohio, April 6, 2016

CrossChx, the leader in healthcare identity, today announced it has raised a $15 million Series C financing round. Participants include Silicon Valley Bank, Khosla Ventures, Drive Capital, NCT Ventures and Moonshots Capital. The financing will be used to aggressively expand sales and distribution of Queue, the company’s flagship patient sign-in system used in hundreds of locations across the country.

“Queue finally provides a way for patients to safely log in to healthcare, giving providers the ability to deliver a more personable level of care and returning control of patient identities back to their rightful owners – the patients themselves,” said Sean Lane, Founder and CEO of CrossChx. “Queue signals a new era of patient registration, and this capital will provide the resources to fulfill demand and expand across the country.”

Since its founding in 2012, CrossChx has signed more than 350 health systems nationwide and created more than 50 million unique patient IDs for healthcare.

“Few companies in healthcare have achieved as much progress as quickly as CrossChx,” said Chris Olsen, Partner with Drive Capital. “We are continually inspired by the company’s passionate, revolutionary approach to creating patient-centered, data-rich solutions that improve processes for everyone, and we are pleased to play a role in its future.”

The Queue patient sign-in system is equipped with the company’s identity resolution software that accurately captures patient data, deduplicates records, catches errors in patient medical profiles, and verifies patients’ identities to prevent medical mistakes.